Page last updated: 2024-09-05

dabigatran and Hip Fractures

dabigatran has been researched along with Hip Fractures in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Alonso, A; Chen, LY; Diem, SJ; Ensrud, KE; Lutsey, PL; MacLehose, RF; Norby, FL1
Chan, EW; Cheung, CL; Lam, JKY; Lau, WCY; Lee, ACH; Lip, GYH; Man, KKC; Sing, CW; Siu, CW; Wong, ICK1
Chan, EW; Cheung, CL; Lam, JK; Lau, WC; Lee, AC; Lip, GY; Man, KK; Sing, CW; Siu, CW; Wong, IC1
Lehre, I; Molden, E; Ranhoff, AH; Viktil, KK1
PottegÄrd, A; Rasmussen, LE; Viberg, BL1
Cerbone, AM; Coppola, A; Franchini, M; Ruosi, C; Tufano, A1

Reviews

1 review(s) available for dabigatran and Hip Fractures

ArticleYear
Preventing postsurgical venous thromboembolism: pharmacological approaches.
    Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3

    Topics: Aged; Anticoagulants; Antithrombins; Arthroscopy; Bariatric Surgery; Benzimidazoles; Blood Coagulation Disorders, Inherited; Dabigatran; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Kidney; Knee; Laparoscopy; Morpholines; Neoplasms; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism

2011

Other Studies

5 other study(ies) available for dabigatran and Hip Fractures

ArticleYear
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
    JAMA internal medicine, 2020, 02-01, Volume: 180, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Comorbidity; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Female; Fractures, Bone; Hip Fractures; Hospitalization; Humans; Incidence; Male; Middle Aged; Osteoporosis; Proportional Hazards Models; Protective Factors; Pyrazoles; Pyridones; Rivaroxaban; Warfarin

2020
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Annals of internal medicine, 2020, 07-07, Volume: 173, Issue:1

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Follow-Up Studies; Hip Fractures; Hong Kong; Humans; Male; Osteoporotic Fractures; Pyrazoles; Pyridones; Rivaroxaban; Spinal Fractures; Stroke; Warfarin

2020
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.
    JAMA, 2017, 03-21, Volume: 317, Issue:11

    Topics: Accidental Falls; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Hip Fractures; Hong Kong; Humans; Male; Osteoporotic Fractures; Poisson Distribution; Propensity Score; Retrospective Studies; Risk; Spinal Fractures; Stroke; Warfarin

2017
Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot Study.
    Drugs & aging, 2019, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Hip Fractures; Humans; Male; Pilot Projects; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Warfarin

2019
[Fatal outcome for a patient in treatment with dabigatran suffering a subtrochanteric femoral fracture].
    Ugeskrift for laeger, 2015, Apr-06, Volume: 177, Issue:15

    Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Dabigatran; Fatal Outcome; Female; Hip Fractures; Humans; Radiography; Time-to-Treatment

2015